No headlines found.
CNO Financial Group to Release First Quarter Results on April 29, 2024
PRNewswire (Mon, 15-Apr 4:15 PM ET)
PRNewswire (Wed, 20-Mar 4:15 PM ET)
Bankers Life Recognizes 34 Women Financial Advisors
PRNewswire (Tue, 12-Mar 4:15 PM ET)
PRNewswire (Thu, 7-Mar 4:15 PM ET)
Cognizant Expands Technology Operations Partnership with CNO Financial Group
PRNewswire (Thu, 22-Feb 4:15 PM ET)
AM Best Affirms Credit Ratings of CNO Financial Group, Inc. and Its Life/Health Subsidiaries
Business Wire (Thu, 15-Feb 10:15 AM ET)
CNO Financial Group Declares $0.15 Quarterly Dividend and Announces Virtual Annual Meeting Date
PRNewswire (Tue, 13-Feb 4:15 PM ET)
CNO Financial Group Reports Fourth Quarter and Full Year 2023 Results
PRNewswire (Tue, 6-Feb 4:15 PM ET)
CNO Financial Group to Release Fourth Quarter Results on February 6, 2024
PRNewswire (Tue, 23-Jan 4:15 PM ET)
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
Cno Finl Group trades on the NYSE stock market under the symbol CNO.
As of April 23, 2024, CNO stock price climbed to $26.60 with 437,409 million shares trading.
CNO has a beta of 1.04, meaning it tends to be more sensitive to market movements. CNO has a correlation of 0.33 to the broad based SPY ETF.
CNO has a market cap of $2.89 billion. This is considered a Mid Cap stock.
Last quarter Cno Finl Group reported $1 billion in Revenue and $1.18 earnings per share. This beat revenue expectation by $237 million and exceeded earnings estimates by $.33.
In the last 3 years, CNO stock traded as high as $28.39 and as low as $16.56.
The top ETF exchange traded funds that CNO belongs to (by Net Assets): IJH, VTI, VB, IWM, VBR.
CNO has outperformed the market in the last year with a price return of +24.5% while the SPY ETF gained +24.2%. However, in the short term, CNO had mixed performance relative to the market. It has underperformed in the last 3 months, returning -3.9% vs +4.9% return in SPY. But in the last 2 weeks, CNO shares have fared better than the market returning -1.8% compared to SPY -2.6%.
CNO support price is $26.04 and resistance is $26.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNO stock will trade within this expected range on the day.